The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel.
BACKGROUND
Familial hemiplegic migraine, an autosomal dominant disorder characterized by attacks of transient hemiparesis followed by a migraine headache, is classically divided into pure familial hemiplegic migraine (affecting 80 percent of families) and familial hemiplegic migraine with permanent cerebellar signs (affecting 20 percent of families). Mutations in CACNA1A, which encodes a neuronal calcium channel, are present in 50 percent of families with hemiplegic migraine, including all those with cerebellar signs. We studied the various clinical manifestations associated with mutations in CACNA1A in families with hemiplegic migraine with and without cerebellar signs.


METHODS
CACNA1A was analyzed and nine mutations were detected in 15 of 16 probands of families affected by hemiplegic migraine and cerebellar signs, in 2 of 3 subjects with sporadic hemiplegic migraine and cerebellar signs, and in 4 of 12 probands of families affected by pure hemiplegic migraine. Genotyping of probands and relatives identified a total of 117 subjects with mutations whose clinical manifestations were assessed in detail.


RESULTS
Eighty-nine percent of the subjects with mutations had attacks of hemiplegic migraine. One third had severe attacks with coma, prolonged hemiplegia, or both, with full recovery. All nine mutations, including five newly identified ones, were missense mutations. Six mutations were associated with hemiplegic migraine and cerebellar signs, and 83 percent of the subjects with these six mutations had nystagmus, ataxia, or both. Three mutations were associated with pure hemiplegic migraine.


CONCLUSIONS
Hemiplegic migraine in subjects with mutations in CACNA1A has a broad clinical spectrum. This clinical variability is partially associated with the various types of mutations.
Ducros
A
A
INSERM E99-21, Faculté de Médecine Lariboisière, Paris, France. anne.ducros@lrb.ap-hop-paris.fr
Denier
C
C
Joutel
A
A
Cecillon
M
M
Lescoat
C
C
Vahedi
K
K
Darcel
F
F
Vicaut
E
E
Bousser
M G
MG
Tournier-Lasserve
E
E
D017668:Age of Onset; D001259:Ataxia / Q000209:etiology; D015220:Calcium Channels / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D020325:Migraine with Aura / Q000145:classification / Q000150:complications / Q000235:genetics*; D020125:Mutation, Missense; D009759:Nystagmus, Pathologic / Q000209:etiology; D010291:Paresis / Q000209:etiology; D010375:Pedigree; D010641:Phenotype; D020864:Calcium Channels, N-Type
D015220:Calcium Channels; C105656:CACNA1A protein, human; D020864:Calcium Channels, N-Type